Standalone figures · ₹ crore
| ₹ Cr | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62 | 63 | 73 | 87 | 101 | 127 | 148 | 117 | 121 | 115 | 134 | 125 | |
| COGS | 38 | 39 | 43 | 54 | 66 | 87 | 100 | 69 | 71 | 61 | 83 | 66 |
| Gross profit | 24 | 24 | 31 | 32 | 36 | 40 | 48 | 47 | 51 | 54 | 51 | 59 |
| 18 | 18 | 22 | 22 | 24 | 26 | 31 | 32 | 32 | 33 | 30 | 33 | |
| 6 | 7 | 9 | 10 | 12 | 15 | 17 | 16 | 19 | 21 | 21 | 26 | |
| OPM % | 9.8% | 10.7% | 12% | 12.1% | 11.8% | 11.5% | 11.8% | 13.5% | 15.4% | 18.5% | 16% | 20.7% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Interest | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 4 | 4 | 3 | 1 | 4 | 4 | 7 | 6 | 5 | 5 | 14 | 8 | |
| Profit before tax | 8 | 9 | 9 | 10 | 15 | 17 | 23 | 20 | 22 | 25 | 33 | 32 |
| Tax | 2 | 2 | 2 | 2 | 4 | 4 | 6 | 5 | 6 | 6 | 8 | 7 |
| Tax % | 23.8% | 25.4% | 26.7% | 24.5% | 25.3% | 24.3% | 24% | 22.4% | 24.7% | 24.7% | 25.2% | 22.9% |
| 6 | 6 | 7 | 8 | 11 | 13 | 18 | 16 | 17 | 19 | 25 | 25 | |
| PAT margin % | 10% | 10.1% | 9.2% | 8.8% | 10.8% | 10.1% | 11.8% | 13.5% | 13.9% | 16.5% | 18.3% | 19.7% |
| EPS (₹) | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 |
| Results filing | — | — | — | — | — | — | — | Results filing for Jun 2025 | Results filing for Sep 2025 | Results filing for Dec 2025 | Results filing for Mar 2026 | Results filing for Jun 2026 |
| vs same quarter last year | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % | -5.3% | -24.7% | +11.8% | +46.3% | +62.7% | +100.6% | +102.6% | +34.2% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 30 Jun 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed |
|---|---|---|---|---|---|
| Pharmaceuticals Drugs & Formulations | 131.36 | 31.35 | 455 | 105.63 | 349.37 |
| Renting of Properties | 0.84 | 0.77 | 92.57 | 2.84 | 89.73 |
| +19.7% |
| -9.8% |
| -9.7% |
| +7% |
| PAT YoY % | -32.8% | -35.9% | -2.9% | +79.5% | +76.3% | +99.2% | +159.3% | +106.2% | +53.8% | +47.5% | +40.4% | +56.3% |
| Trading of Commodities | 0.28 | 0.02 | 0.05 | 0.13 | — |
₹ crore by quarter